Vol. 6, No. 4, 2009        August 2009     Original Paper 139 Oligomerization Partially Explains the Lowering of A42 in Alzheimer's Disease Cerebrospinal Fluid Englund, H. ;    Degerman Gunnarsson, M. ;    Brundin, R.M. ;    Hedlund, M. ;    Kilander, L. ;    Lannfelt, L. ;    Ekholm Pettersson, F.  Neurodegenerative Dis 2009;6:139-147 (DOI:10.1159/000225376)      Free Abstract     Article (References)     Article (PDF 323 KB)      Free Supplementary Material 148 Evaluation of the Size and Area of the Corpus Callosum with the Osiris Method in Alzheimer's Disease Kabay, S.C. ;    Gulbandilar, E. ;    Ozden, H. ;    Ozbag, D. ;    Guven, G. ;    Adapinar, B. ;    Durmaz, R.  Neurodegenerative Dis 2009;6:148-153 (DOI:10.1159/000225375)      Free Abstract     Article (References)     Article (PDF 246 KB)      Modeling Neurodegenerative Diseases in vivo 154 Huntington's Disease - New Perspectives Based on Neuroendocrine Changes in Rodent Models Petersén, Å. ;    Hult, S. ;    Kirik, D.  Neurodegenerative Dis 2009;6:154-164 (DOI:10.1159/000225377)      Free Abstract     Article (References)     Article (PDF 315 KB)      Clinical Drug Trial Section 165 List of Drugs in Development for Neurodegenerative Diseases: Update June 2009 Pogai, V. ;    Herrling, P.  Neurodegenerative Dis 2009;6:165-212 (DOI:10.1159/000232576)      Article (PDF 433 KB)        Journal Home Journal Content Guidelines Editorial Board Aims and Scope Subscriptions Library Recommendation Search in this issue Now listed in MEDLINE/PubMed! For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.  © 2009 S. Karger AG, Basel